Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis

C. Bosetti, P. Bertuccio, F. Levi, F. Lucchini, E. Negri, C. La Vecchia

Research output: Contribution to journalArticle

Abstract

Background: Cancer mortality peaked in the European Union (EU) in the late 1980s and declined thereafter. Materials and methods: We analyzed EU cancer mortality data provided by the World Health Organization in 1970-2003, using joinpoint analysis. Results: Overall, cancer mortality levelled off in men since 1988 and declined in 1993-2003 (annual percent change, APC = -1.3%). In women, a steady decline has been observed since the early 1970s. The decline in male cancer mortality has been driven by lung cancer, which levelled off since the late 1980s and declined thereafter (APC = -2.7% in 1997-2003). Recent decreases were also observed for other tobacco-related cancers, as oral cavity/pharynx, esophagus, larynx and bladder, as well as for colorectal (APC = -0.9% in 1992-2003) and prostate cancers (APC = -1.0% in 1994-2003). In women, breast cancer mortality levelled off since the early 1990s and declined thereafter (APC = -0% in 1998-2003). Female mortality declined through the period 1970-2003 for colorectal and uterine cancer, while it increased over the last three decades for lung cancer (APC = 4.6% in 2001-2003). In both sexes, mortality declined in 1970-2003 for stomach cancer and for a few cancers amenable to treatment. Conclusion: This update analysis of the mortality from cancer in the EU shows favorable patterns over recent years in both sexes.

Original languageEnglish
Pages (from-to)631-640
Number of pages10
JournalAnnals of Oncology
Volume19
Issue number4
DOIs
Publication statusPublished - Apr 2008

Fingerprint

European Union
Mortality
Neoplasms
Lung Neoplasms
Uterine Neoplasms
Mouth Neoplasms
Larynx
Pharynx
Esophagus
Stomach Neoplasms
Tobacco
Mouth
Colorectal Neoplasms
Prostatic Neoplasms
Urinary Bladder
Breast Neoplasms

Keywords

  • Cancer
  • European Union
  • Mortality
  • Trends

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bosetti, C., Bertuccio, P., Levi, F., Lucchini, F., Negri, E., & La Vecchia, C. (2008). Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Annals of Oncology, 19(4), 631-640. https://doi.org/10.1093/annonc/mdm597

Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. / Bosetti, C.; Bertuccio, P.; Levi, F.; Lucchini, F.; Negri, E.; La Vecchia, C.

In: Annals of Oncology, Vol. 19, No. 4, 04.2008, p. 631-640.

Research output: Contribution to journalArticle

Bosetti, C, Bertuccio, P, Levi, F, Lucchini, F, Negri, E & La Vecchia, C 2008, 'Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis', Annals of Oncology, vol. 19, no. 4, pp. 631-640. https://doi.org/10.1093/annonc/mdm597
Bosetti, C. ; Bertuccio, P. ; Levi, F. ; Lucchini, F. ; Negri, E. ; La Vecchia, C. / Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. In: Annals of Oncology. 2008 ; Vol. 19, No. 4. pp. 631-640.
@article{7eaf70fac04a491f81b16211a0f5f02d,
title = "Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis",
abstract = "Background: Cancer mortality peaked in the European Union (EU) in the late 1980s and declined thereafter. Materials and methods: We analyzed EU cancer mortality data provided by the World Health Organization in 1970-2003, using joinpoint analysis. Results: Overall, cancer mortality levelled off in men since 1988 and declined in 1993-2003 (annual percent change, APC = -1.3{\%}). In women, a steady decline has been observed since the early 1970s. The decline in male cancer mortality has been driven by lung cancer, which levelled off since the late 1980s and declined thereafter (APC = -2.7{\%} in 1997-2003). Recent decreases were also observed for other tobacco-related cancers, as oral cavity/pharynx, esophagus, larynx and bladder, as well as for colorectal (APC = -0.9{\%} in 1992-2003) and prostate cancers (APC = -1.0{\%} in 1994-2003). In women, breast cancer mortality levelled off since the early 1990s and declined thereafter (APC = -0{\%} in 1998-2003). Female mortality declined through the period 1970-2003 for colorectal and uterine cancer, while it increased over the last three decades for lung cancer (APC = 4.6{\%} in 2001-2003). In both sexes, mortality declined in 1970-2003 for stomach cancer and for a few cancers amenable to treatment. Conclusion: This update analysis of the mortality from cancer in the EU shows favorable patterns over recent years in both sexes.",
keywords = "Cancer, European Union, Mortality, Trends",
author = "C. Bosetti and P. Bertuccio and F. Levi and F. Lucchini and E. Negri and {La Vecchia}, C.",
year = "2008",
month = "4",
doi = "10.1093/annonc/mdm597",
language = "English",
volume = "19",
pages = "631--640",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "4",

}

TY - JOUR

T1 - Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis

AU - Bosetti, C.

AU - Bertuccio, P.

AU - Levi, F.

AU - Lucchini, F.

AU - Negri, E.

AU - La Vecchia, C.

PY - 2008/4

Y1 - 2008/4

N2 - Background: Cancer mortality peaked in the European Union (EU) in the late 1980s and declined thereafter. Materials and methods: We analyzed EU cancer mortality data provided by the World Health Organization in 1970-2003, using joinpoint analysis. Results: Overall, cancer mortality levelled off in men since 1988 and declined in 1993-2003 (annual percent change, APC = -1.3%). In women, a steady decline has been observed since the early 1970s. The decline in male cancer mortality has been driven by lung cancer, which levelled off since the late 1980s and declined thereafter (APC = -2.7% in 1997-2003). Recent decreases were also observed for other tobacco-related cancers, as oral cavity/pharynx, esophagus, larynx and bladder, as well as for colorectal (APC = -0.9% in 1992-2003) and prostate cancers (APC = -1.0% in 1994-2003). In women, breast cancer mortality levelled off since the early 1990s and declined thereafter (APC = -0% in 1998-2003). Female mortality declined through the period 1970-2003 for colorectal and uterine cancer, while it increased over the last three decades for lung cancer (APC = 4.6% in 2001-2003). In both sexes, mortality declined in 1970-2003 for stomach cancer and for a few cancers amenable to treatment. Conclusion: This update analysis of the mortality from cancer in the EU shows favorable patterns over recent years in both sexes.

AB - Background: Cancer mortality peaked in the European Union (EU) in the late 1980s and declined thereafter. Materials and methods: We analyzed EU cancer mortality data provided by the World Health Organization in 1970-2003, using joinpoint analysis. Results: Overall, cancer mortality levelled off in men since 1988 and declined in 1993-2003 (annual percent change, APC = -1.3%). In women, a steady decline has been observed since the early 1970s. The decline in male cancer mortality has been driven by lung cancer, which levelled off since the late 1980s and declined thereafter (APC = -2.7% in 1997-2003). Recent decreases were also observed for other tobacco-related cancers, as oral cavity/pharynx, esophagus, larynx and bladder, as well as for colorectal (APC = -0.9% in 1992-2003) and prostate cancers (APC = -1.0% in 1994-2003). In women, breast cancer mortality levelled off since the early 1990s and declined thereafter (APC = -0% in 1998-2003). Female mortality declined through the period 1970-2003 for colorectal and uterine cancer, while it increased over the last three decades for lung cancer (APC = 4.6% in 2001-2003). In both sexes, mortality declined in 1970-2003 for stomach cancer and for a few cancers amenable to treatment. Conclusion: This update analysis of the mortality from cancer in the EU shows favorable patterns over recent years in both sexes.

KW - Cancer

KW - European Union

KW - Mortality

KW - Trends

UR - http://www.scopus.com/inward/record.url?scp=41549131651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41549131651&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdm597

DO - 10.1093/annonc/mdm597

M3 - Article

C2 - 18281267

AN - SCOPUS:41549131651

VL - 19

SP - 631

EP - 640

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 4

ER -